The SORAYA study (NCT04296890), which exclusively enrolled FRα‐high patients, consisted of 106 individuals with high‐grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer. Here, FOLR1 is linked to peritoneum cancer.